All In Biotech

Free tool

FAERS Monitor: Normosol-R In Plastic Container

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 017586 or its brand name (Normosol-R In Plastic Container, Magnesium Chloride, Potassium Chloride, Sodium Acetate, Sodium Chloride, Sodium Gluconate). Reports on generic versions are filed under their own applications.

Reports

30

Serious

26

87% of reports

Hospitalization

17

Death reported

9

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • metabolic acidosis5
  • hyperkalaemia4
  • acute kidney injury3
  • hypoxia3
  • sepsis3
  • acute respiratory failure2
  • ascites2
  • cellulitis2
  • fatigue2
  • hyperglycaemia2
  • intestinal perforation2
  • paradoxical drug reaction2
  • pyrexia2
  • respiratory failure2
  • septic shock2

Reports by year received

View as table
YearReports
20153
20166
20172
20181
20192
202010
20211
20221
20231
20241
20252

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,129 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
paradoxical drug reaction2381.399.9426
intestinal perforation2124.932.7138
metabolic acidosisSignal5109.649.3436
hyperkalaemiaSignal480.032.1238
acute respiratory failure272.919.179
hypoxiaSignal359.720.4120
ascites247.712.551
hyperglycaemia238.510.140
septic shock232.28.433
cellulitis227.87.328
respiratory failure219.25.019
sepsisSignal318.96.435
acute kidney injurySignal313.74.724
pyrexia24.11.12
fatigue21.80.50

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.